1. Home
  2. STRS vs IPHA Comparison

STRS vs IPHA Comparison

Compare STRS & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRS
  • IPHA
  • Stock Information
  • Founded
  • STRS 1992
  • IPHA 1999
  • Country
  • STRS United States
  • IPHA France
  • Employees
  • STRS N/A
  • IPHA N/A
  • Industry
  • STRS Homebuilding
  • IPHA Biotechnology: Pharmaceutical Preparations
  • Sector
  • STRS Real Estate
  • IPHA Health Care
  • Exchange
  • STRS Nasdaq
  • IPHA Nasdaq
  • Market Cap
  • STRS 146.8M
  • IPHA 160.1M
  • IPO Year
  • STRS N/A
  • IPHA 2019
  • Fundamental
  • Price
  • STRS $18.33
  • IPHA $1.97
  • Analyst Decision
  • STRS
  • IPHA Strong Buy
  • Analyst Count
  • STRS 0
  • IPHA 1
  • Target Price
  • STRS N/A
  • IPHA $11.50
  • AVG Volume (30 Days)
  • STRS 7.8K
  • IPHA 28.5K
  • Earning Date
  • STRS 05-13-2025
  • IPHA 03-27-2025
  • Dividend Yield
  • STRS N/A
  • IPHA N/A
  • EPS Growth
  • STRS N/A
  • IPHA N/A
  • EPS
  • STRS 0.24
  • IPHA N/A
  • Revenue
  • STRS $54,183,000.00
  • IPHA $20,831,349.00
  • Revenue This Year
  • STRS N/A
  • IPHA $220.44
  • Revenue Next Year
  • STRS N/A
  • IPHA $81.85
  • P/E Ratio
  • STRS $76.38
  • IPHA N/A
  • Revenue Growth
  • STRS 213.74
  • IPHA N/A
  • 52 Week Low
  • STRS $15.50
  • IPHA $1.29
  • 52 Week High
  • STRS $30.66
  • IPHA $3.51
  • Technical
  • Relative Strength Index (RSI)
  • STRS 50.28
  • IPHA 53.30
  • Support Level
  • STRS $17.90
  • IPHA $1.81
  • Resistance Level
  • STRS $19.36
  • IPHA $2.00
  • Average True Range (ATR)
  • STRS 1.48
  • IPHA 0.14
  • MACD
  • STRS 0.07
  • IPHA 0.02
  • Stochastic Oscillator
  • STRS 52.31
  • IPHA 53.76

About STRS Stratus Properties Inc.

Stratus Properties Inc is a diversified real estate company operating in the United States. It is engaged in the acquisition, entitlement, development, management, operation and sale of commercial, multi- and single-family residential real estate properties, located in the Austin Texas area and other select markets in Texas. It operates its business through two segments namely, Real Estate Operations and Leasing Operations.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.

Share on Social Networks: